Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma.
Kong X, Zhang X, Ding M, Feng X, Dong M, Zhang L, Fu X, Li L, Li X, Sun Z, Yan J, Wang X, Wu X, Chen Q, Zhang M, Zhu L.
Kong X, et al. Among authors: yan j.
Cancer Med. 2023 Apr;12(7):8134-8143. doi: 10.1002/cam4.5615. Epub 2023 Jan 25.
Cancer Med. 2023.
PMID: 36695162
Free PMC article.
Clinical Trial.